118 related articles for article (PubMed ID: 1669701)
1. Structural and functional aspects of the interaction of inflammatory cells with the blood-brain barrier in experimental brain inflammation.
Wisniewski HM; Lossinsky AS
Brain Pathol; 1991 Jan; 1(2):89-96. PubMed ID: 1669701
[TBL] [Abstract][Full Text] [Related]
2. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
Lossinsky AS; Shivers RR
Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
[TBL] [Abstract][Full Text] [Related]
3. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
4. Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier.
Abadier M; Haghayegh Jahromi N; Cardoso Alves L; Boscacci R; Vestweber D; Barnum S; Deutsch U; Engelhardt B; Lyck R
Eur J Immunol; 2015 Apr; 45(4):1043-58. PubMed ID: 25545837
[TBL] [Abstract][Full Text] [Related]
5. Factors modifying the migration of lymphocytes across the blood-brain barrier.
Brown KA
Int Immunopharmacol; 2001 Nov; 1(12):2043-62. PubMed ID: 11710535
[TBL] [Abstract][Full Text] [Related]
6. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
7. Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis.
Elo P; Tadayon S; Liljenbäck H; Teuho J; Käkelä M; Koskensalo K; Saunavaara V; Virta J; Veres TZ; Kiviniemi A; Saraste A; Marjamäki P; Airas L; Jalkanen S; Roivainen A
J Neuroinflammation; 2018 May; 15(1):128. PubMed ID: 29716612
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.
van der Laan LJ; van der Goes A; Wauben MH; Ruuls SR; Döpp EA; De Groot CJ; Kuijpers TW; Elices MJ; Dijkstra CD
J Neurosci Res; 2002 Jan; 67(2):191-9. PubMed ID: 11782963
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis.
Göbel K; Schuhmann MK; Pankratz S; Stegner D; Herrmann AM; Braun A; Breuer J; Bittner S; Ruck T; Wiendl H; Kleinschnitz C; Nieswandt B; Meuth SG
Eur J Immunol; 2014 Aug; 44(8):2295-305. PubMed ID: 24811005
[TBL] [Abstract][Full Text] [Related]
10. P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice.
Engelhardt B; Kempe B; Merfeld-Clauss S; Laschinger M; Furie B; Wild MK; Vestweber D
J Immunol; 2005 Jul; 175(2):1267-75. PubMed ID: 16002731
[TBL] [Abstract][Full Text] [Related]
11. Going against the tide--how encephalitogenic T cells breach the blood-brain barrier.
Lyck R; Engelhardt B
J Vasc Res; 2012; 49(6):497-509. PubMed ID: 22948545
[TBL] [Abstract][Full Text] [Related]
12. Role of glucocorticoids on T cell recruitment across the blood-brain barrier.
Engelhardt B
Z Rheumatol; 2000; 59 Suppl 2():II/18-21. PubMed ID: 11155798
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells.
Claudio L; Kress Y; Factor J; Brosnan CF
Am J Pathol; 1990 Nov; 137(5):1033-45. PubMed ID: 2240157
[TBL] [Abstract][Full Text] [Related]
14. TET inducible expression of the α4β7-integrin ligand MAdCAM-1 on the blood-brain barrier does not influence the immunopathogenesis of experimental autoimmune encephalomyelitis.
Döring A; Pfeiffer F; Meier M; Dehouck B; Tauber S; Deutsch U; Engelhardt B
Eur J Immunol; 2011 Mar; 41(3):813-21. PubMed ID: 21341265
[TBL] [Abstract][Full Text] [Related]
15. Endothelial α6β4 integrin protects during experimental autoimmune encephalomyelitis-induced neuroinflammation by maintaining vascular integrity and tight junction protein expression.
Welser JV; Halder SK; Kant R; Boroujerdi A; Milner R
J Neuroinflammation; 2017 Nov; 14(1):217. PubMed ID: 29121970
[TBL] [Abstract][Full Text] [Related]
16. E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice.
Döring A; Wild M; Vestweber D; Deutsch U; Engelhardt B
J Immunol; 2007 Dec; 179(12):8470-9. PubMed ID: 18056394
[TBL] [Abstract][Full Text] [Related]
17. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
Prasad R; Giri S; Nath N; Singh I; Singh AK
J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
[TBL] [Abstract][Full Text] [Related]
18. Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination.
Raine CS; Cannella B; Duijvestijn AM; Cross AH
Lab Invest; 1990 Oct; 63(4):476-89. PubMed ID: 1700193
[TBL] [Abstract][Full Text] [Related]
19. E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis.
Engelhardt B; Vestweber D; Hallmann R; Schulz M
Blood; 1997 Dec; 90(11):4459-72. PubMed ID: 9373256
[TBL] [Abstract][Full Text] [Related]
20. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
